2019
DOI: 10.1016/j.colsurfa.2018.12.049
|View full text |Cite
|
Sign up to set email alerts
|

Microgels as carriers of antimicrobial peptides – Effects of peptide PEGylation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
26
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(28 citation statements)
references
References 39 publications
2
26
0
Order By: Relevance
“…Most of the work done regarding microgels with antimicrobial activity deals with the drug delivery ability of microgels capable to carry and release antibiotics or antimicrobial agents [22,23,24,25]. Malmsten et al first studied the existing interactions between antimicrobial peptides (AMP) and poly(acrylic acid) microgels and peptide uptake and sustained release [26,27,28].…”
Section: Introductionmentioning
confidence: 99%
“…Most of the work done regarding microgels with antimicrobial activity deals with the drug delivery ability of microgels capable to carry and release antibiotics or antimicrobial agents [22,23,24,25]. Malmsten et al first studied the existing interactions between antimicrobial peptides (AMP) and poly(acrylic acid) microgels and peptide uptake and sustained release [26,27,28].…”
Section: Introductionmentioning
confidence: 99%
“…[9] As a result, the majority of clinical applicable AMPs are used or designed for topical applications only with very few exceptions aimed for systematic applications. [5] To overcome these limitations, many different strategies, including but not limited to structural/ sequence modification, [10][11][12][13] specific delivery system design, [14][15][16][17] "smart" AMPs [18][19][20] and de novo designed antimicrobial peptides/peptidomimetics [21][22][23][24][25][26][27] have been developed to efficiently use AMPs without being hindered by their side-effects. Among these strategies, modification or mimicry of naturally occurring peptides with natural amino acids or unnatural building blocks is an efficient pathway.…”
Section: Introductionmentioning
confidence: 99%
“…However, some undesirable characteristics, such as high toxicity, easy degradation, and low bioavailability by binding to serum proteins, mucins, and other anionic components, have impaired the clinical translation of AMPs [ 240 , 241 ]. Therefore, recently increased attention has been placed on nanogels as carriers for the delivery of AMPs to improve the antimicrobial performance [ [243] , [244] , [245] , [246] , [247] , [248] , [249] , [250] ]. The Malmsten group investigated cationic AMPs incorporated into anionic poly (ethyl acrylate- co -methacrylic acid) (MAA) nanogels in different ways that influenced the encapsulation efficiency and release of AMPs, and the membrane interactions and antimicrobial effects of those nanogels.…”
Section: Nanogel-based Antimicrobial Systemsmentioning
confidence: 99%